Navigation Links
Align Technology Announces ClearCorrect's Filing of Notice of Voluntary Dismissal of Complaint
Date:4/13/2009

SANTA CLARA, Calif., April 13 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN) today announced that in response to the motion to dismiss filed by Align on March 26, 2009, ClearCorrect has dismissed, in its entirety, the declaratory judgment complaint it filed against Align on February 17, 2009. ClearCorrect filed the notice of dismissal on April 9, 2009, rather than oppose Align's motion, which would have been decided by the Court sometime after April 15. The notice of dismissal terminates the lawsuit.

Align's motion to dismiss vigorously contested ClearCorrect's right to seek declaratory relief on the ground that the lawsuit was premature because of the absence of communication between Align and ClearCorrect, the limited information available to Align regarding ClearCorrect's process and products, and the failure of ClearCorrect to provide any details to support its allegation that Align's patents were invalid. ClearCorrect chose to withdraw its allegations and dismiss its complaint instead of responding to these arguments.

Align does not currently have enough information to determine whether ClearCorrect's processes and products incorporate technology covered by any of Align's numerous patents or other intellectual property. Align was and is not now in a position to make a determination regarding the propriety of ClearCorrect's activities or Align's likely response should the Company ultimately conclude that those activities infringe any of Align's intellectual property rights. Align unequivocally reserved its right to proceed against ClearCorrect should it determine that ClearCorrect is violating Align's intellectual property rights.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998. Today, the Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express, and Vivera Retainers.

To learn more about Invisalign or to find an Invisalign-trained doctor in your area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.

    Investor Relations Contact                  Press Contact
    Shirley Stacy                               Shannon Mangum Henderson
    Align Technology, Inc.                      Ethos Communication, Inc.
    (408) 470-1150                              (678) 540-9222
    sstacy@aligntech.com                        align@ethoscommunication.com


'/>"/>
SOURCE Align Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum and IBM Align to Drive Medical Home Solution
2. ABAXIS Realigns North American Medical Sales and Marketing
3. Align Technology to Announce First Quarter Fiscal 2009 Results on April 23, 2009
4. NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System
5. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
6. Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
7. A new measure for the malignancy of melanoma
8. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
9. Precyse Solutions Adds Executives, Realigns Around Service Lines
10. Align Technology Announces International Availability of Invisalign Teen(TM)
11. EMSI Realigns Internal Divisions for More Effective Focus on Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: